CN Patent

CN202211874U — 一种复方辛伐他汀烟酸双释片胶囊

Assigned to GUANGXI NANNING KEGUAN MEDICINE SCIENCE & TECHNOLOGY DEVELOPMENT CO., LTD. · Expires 2012-05-09 · 14y expired

What this patent protects

本实用新型公开了一种复方辛伐他汀烟酸双释片胶囊，属于药品剂型结构技术领域，包括胶囊囊壳和装入胶囊囊壳内的药物，其中所述的药物的剂型形式为两种释放药物速度不同的片剂，分别为缓释片剂(a)和速释片剂(b)，所述的缓释片剂(a)为烟酸片，所述的速释片剂(b)为辛伐他汀片。

USPTO Abstract

本实用新型公开了一种复方辛伐他汀烟酸双释片胶囊，属于药品剂型结构技术领域，包括胶囊囊壳和装入胶囊囊壳内的药物，其中所述的药物的剂型形式为两种释放药物速度不同的片剂，分别为缓释片剂(a)和速释片剂(b)，所述的缓释片剂(a)为烟酸片，所述的速释片剂(b)为辛伐他汀片。

Drugs covered by this patent

Patent Metadata

Patent number
CN202211874U
Jurisdiction
CN
Classification
—
Expires
2012-05-09
Drug substance claim
No
Drug product claim
No
Assignee
GUANGXI NANNING KEGUAN MEDICINE SCIENCE & TECHNOLOGY DEVELOPMENT CO., LTD.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.